Meridian Bioscience

Meridian Bioscience Dividend Growth

The Year-over-Year Dividend Growth of Meridian Bioscience (VIVO) as of Oct 26, 2026 is -75.00 %.

Dividend Growth

-75.00 %

Last updated:

Year-over-Year Dividend Growth of Meridian Bioscience is 2019 -75.00 % . Year-over-Year Dividend Growth of Meridian Bioscience was 2018 0.00 . It decreases by % lower compared to the previous year.

The Meridian Bioscience Dividend Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend Growth
Date
Dividend Growth
Jan 1, 2015
0.00 USD
Jan 1, 2016
0.00 USD
Jan 1, 2017
-37.50 USD
Jan 1, 2018
0.00 USD
Jan 1, 2019
-75.00 USD
The Meridian Bioscience Dividend Growth history
YEARDividend GrowthYoY
-75.00 %—
0.00-100.00%
-37.50 %—
0.00—
0.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Meridian Bioscience Stock analysis

What does Meridian Bioscience do? Meridian Bioscience Inc. is a global company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. The company was founded in 1976 by William J. Motto and initially focused on the development of enzyme immunoassays (EIA). Over the years, the company has grown and diversified its product offerings, becoming a leading provider of diagnostic test kits for acute and chronic medical conditions, infectious diseases, gastrointestinal infections, and virology. The company's success is attributed to its diverse range of test kits in various medical areas, including immunology, infectious diseases, sexually transmitted diseases, gastroenterology, and virology. Additionally, Meridian Bioscience Inc. stays up-to-date with the latest technological advancements in biotechnology to ensure the fast and effective performance of its tests. The company operates globally, collaborating with universities, research institutions, government agencies, and distributors to ensure the worldwide distribution and marketing of its products. In summary, Meridian Bioscience Inc. is an innovative company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. Its wide range of products, including immunology products, infectious disease diagnostics, sexually transmitted disease test kits, gastroenterology, virology, and molecular diagnostics, coupled with advanced technologies, provides fast, accurate, and reliable diagnostic support. Meridian Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Meridian Bioscience stock

Year-over-Year Dividend Growth of Meridian Bioscience is -75.00 % in 2019.

On Eulerpool you can find the complete historical development of Year-over-Year Dividend Growth Meridian Bioscience since 2006 – with annual values, charts, and detailed analysis.

Dividend growth measures the percentage increase in dividends compared to the previous year. Consistent dividend growth signals financial strength and shareholder commitment.

To evaluate Year-over-Year Dividend Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Dividend Growth.

Year-over-Year Dividend Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Dividend Growth's Meridian Bioscience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Meridian Bioscience

All Key Metrics — Meridian Bioscience